caption
stringlengths 6
2.51k
|
|---|
The molecule is a energy storage, a emulsifier, a stabilizing cytochrome oxidase, and smooth. The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts diabetic heart disease, tangier disease, and non-alcoholic fatty liver disease. The molecule is a apoptosis, a energy source, and a membrane stabilizer, and it impacts aging. The molecule is a surfactant, food additive, nutritional supplement, proton trap for oxidative phosphorylation that impacts barth syndrome. |
The molecule is a membrane stabilizer and a nutrient, belonging to the anti oxidant class of molecules. The molecule is a energy storage, surfactant, emulsifier, energy source. |
The molecule is a energy storage, a membrane stabilizer, and a energy source, and it impacts non-alcoholic fatty liver disease. The molecule is a food additive, nutritional supplement, emulsifier that impacts diabetic heart disease and aging. The molecule is a apoptosis, proton trap for oxidative phosphorylation, cholesterol translocation, stabilizing mitochondrial structure. The molecule is a stabilizing cytochrome oxidase and a surfactant, which impacts both tangier disease and barth syndrome, and is characterized as smooth. |
The molecule is both a 5lipoxygenase inhibitor and a lipoxygenase inhibitor. |
The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase that impacts barth syndrome, aging, and tangier disease. The molecule is a apoptosis, proton trap for oxidative phosphorylation, cholesterol translocation that impacts non-alcoholic fatty liver disease and diabetic heart disease. |
The molecule is a kinase modulator. |
The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts tangier disease, barth syndrome, and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure, cholesterol translocation, stabilizing cytochrome oxidase that impacts aging and diabetic heart disease. |
The molecule is a proton trap for oxidative phosphorylation and a apoptosis that impacts aging, diabetic heart disease, and tangier disease. The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, cholesterol translocation that impacts barth syndrome and non-alcoholic fatty liver disease. |
It has an effect on colorectal cancer, and impacts stomach cancer, breast cancer, and cardiovascular disease. It impacts seizure, alzheimer's disease, diabetes mellitus, and parkinson's disease. |
The molecule is a stabilizing cytochrome oxidase, a surfactant, a energy storage, and smooth. The molecule is a apoptosis, stabilizing mitochondrial structure, membrane stabilizer, emulsifier that impacts non-alcoholic fatty liver disease. The molecule is a nutritional supplement and a energy source, impacting both tangier disease and diabetic heart disease. The molecule is a food additive, proton trap for oxidative phosphorylation, cholesterol translocation that impacts aging and barth syndrome. |
The molecule is a nutrient, energy source, emulsifier, energy storage, surfactant, membrane stabilizer. |
The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, apoptosis that impacts diabetic heart disease and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase and a stabilizing mitochondrial structure that impacts barth syndrome, tangier disease, and aging. |
It belongs to the diabetes treatment class of molecules. |
The molecule is a 11尾hsd1 inhibitor and a obesity treatment, belonging to the metabolic syndrome treatment class of molecules. |
The molecule is a anti tumor and is anti biotic. |
The molecule is a anti biotic. |
The molecule is a stabilizing mitochondrial structure that impacts diabetic heart disease, tangier disease, and aging. The molecule is a membrane stabilizer, cholesterol translocation, energy source that impacts barth syndrome and non-alcoholic fatty liver disease. The molecule is a emulsifier, a stabilizing cytochrome oxidase, a surfactant, and smooth. The molecule is a apoptosis, proton trap for oxidative phosphorylation, food additive, nutritional supplement, energy storage. |
The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts aging, diabetic heart disease, and tangier disease. The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, cholesterol translocation that impacts non-alcoholic fatty liver disease and barth syndrome. |
The molecule is a apoptosis, food additive, proton trap for oxidative phosphorylation, energy storage. The molecule is a surfactant and smooth, impacting tangier disease, aging, and barth syndrome. The molecule is a cholesterol translocation, a emulsifier, and a energy source, and it impacts non-alcoholic fatty liver disease. The molecule is a membrane stabilizer, nutritional supplement, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts diabetic heart disease. |
The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase that impacts aging, tangier disease, and diabetic heart disease. The molecule is a apoptosis, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease and barth syndrome. |
The molecule is a membrane stabilizer, energy source, energy storage, nutrient, emulsifier, surfactant. |
The molecule is a apoptosis, cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts barth syndrome. The molecule is a stabilizing mitochondrial structure that impacts aging, non-alcoholic fatty liver disease, tangier disease, and diabetic heart disease. |
The molecule is a energy source and a fat storage that impacts thyroxine treatment, atherosclerosis, pancreatitis, and cancer. The molecule is a inflammatory and nutrient, and it impacts obesity. The molecule is a energy storage and a membrane stabilizer, impacting both metabolic syndrome and cardiovascular disease. |
The molecule is a apoptosis, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts aging and non-alcoholic fatty liver disease. The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts diabetic heart disease, tangier disease, and barth syndrome. |
The molecule is a nutrient. |
The molecule is a anti bacterial and is anti biotic. |
The molecule is organic light-emitting that impacts electron transport and has an effect on both low driving voltage and low voltage. |
The molecule is both a cancer treatment and a ezh2 inhibitor. |
The molecule is a nutrient and a membrane stabilizer that impacts atherosclerosis, cardiovascular disease, obesity, and thyroxine treatment. The molecule is a inflammatory that impacts both cancer and pancreatitis. The molecule is a energy storage, a fat storage, and a energy source, and it impacts metabolic syndrome. |
The molecule is a flavoring agent, fatty, waxy, and milky. The molecule is a nutrient, creamy, dairy, oil, sweet. |
The molecule is a histone deacetylase inhibitor. |
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, proton trap for oxidative phosphorylation that impacts tangier disease and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts aging, diabetic heart disease, and barth syndrome. |
It belongs to the pain treatment class of molecules. |
The molecule is a nutrient that affects breast cancer by impacting atherosclerosis, cervical cancer, and ulcerative colitis. |
The molecule is a thrombin inhibitor and belongs to the anti coagulant class of molecules. |
The molecule is a cholesterol translocation and a apoptosis that impacts aging, barth syndrome, and tangier disease. The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts diabetic heart disease and non-alcoholic fatty liver disease. |
The molecule is a protease inhibitor and belongs to the anti viral class of molecules. |
The molecule is a cell adhesion inhibitor. |
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, apoptosis that impacts diabetic heart disease and barth syndrome. The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation that impacts tangier disease, aging, and non-alcoholic fatty liver disease. |
The molecule is a stabilizing cytochrome oxidase, apoptosis, stabilizing mitochondrial structure that impacts barth syndrome and non-alcoholic fatty liver disease. The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts aging, diabetic heart disease, and tangier disease. |
The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts barth syndrome, diabetic heart disease, and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, cholesterol translocation that impacts aging and tangier disease. |
It belongs to the anti microbial class of molecules. |
The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, cholesterol translocation that impacts aging and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation and a apoptosis that impacts barth syndrome, tangier disease, and non-alcoholic fatty liver disease. |
The molecule is a neurological treatment. |
The molecule is a cholesterol translocation, stabilizing mitochondrial structure, apoptosis that impacts non-alcoholic fatty liver disease and tangier disease. The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation that impacts aging, diabetic heart disease, and barth syndrome. |
The molecule is a flavoring agent, a nutrient, radish, turnup, and pungent. |
The molecule is a stabilizing cytochrome oxidase, apoptosis, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease and barth syndrome. The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts aging, tangier disease, and diabetic heart disease. |
The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts tangier disease, aging, and barth syndrome. |
The molecule is a fat storage, nutrient, inflammatory that impacts pancreatitis, obesity, and cardiovascular disease. The molecule is a membrane stabilizer and energy storage, and it impacts cancer. The molecule is a energy source that impacts thyroxine treatment, atherosclerosis, and metabolic syndrome. |
It has an effect on colorectal cancer, and impacts stomach cancer, parkinson's disease, and diabetes mellitus. It has an effect on breast cancer, and impacts cardiovascular disease, seizure, and alzheimer's disease. |
The molecule is a electronic device. |
The molecule is a proton trap for oxidative phosphorylation, apoptosis, cholesterol translocation that impacts barth syndrome and aging. The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase that impacts diabetic heart disease, tangier disease, and non-alcoholic fatty liver disease. |
The molecule is a immunomodulator and pd1/pdl1 inhibitor, and it impacts cancer treatment. |
The molecule is a membrane stabilizer, a energy source, and a emulsifier, and it impacts non-alcoholic fatty liver disease. The molecule is a energy storage, a stabilizing cytochrome oxidase, and a surfactant, it impacts tangier disease and is smooth. The molecule is a cholesterol translocation that impacts diabetic heart disease, barth syndrome, and aging. The molecule is a proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, food additive, apoptosis, nutritional supplement. |
The molecule is a cholesterol translocation that impacts aging, tangier disease, diabetic heart disease, and barth syndrome. The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, apoptosis that impacts non-alcoholic fatty liver disease. |
The molecule is a apoptosis and a stabilizing mitochondrial structure that impacts aging, tangier disease, and non-alcoholic fatty liver disease. The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts barth syndrome and diabetic heart disease. |
It belongs to the anti body class of molecules. |
It belongs to the serotonin antagonist class of molecules. |
The molecule is a chemokine receptor antagonist. |
The molecule is a nutrient. |
The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts tangier disease, non-alcoholic fatty liver disease, and barth syndrome. The molecule is a proton trap for oxidative phosphorylation, apoptosis, stabilizing cytochrome oxidase that impacts diabetic heart disease and aging. |
The molecule is a immunomodulator and is cancer treatment. |
The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, cholesterol translocation that impacts tangier disease. The molecule is a stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease, aging, barth syndrome, and diabetic heart disease. |
The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, apoptosis, stabilizing mitochondrial structure that impacts tangier disease. The molecule is a stabilizing cytochrome oxidase that impacts barth syndrome, aging, non-alcoholic fatty liver disease, and diabetic heart disease. |
The molecule is a thyroxine treatment, energy storage, fat storage, inflammatory that impacts pancreatitis and cancer. The molecule is a membrane stabilizer and nutrient, and it impacts obesity. The molecule is a energy source that impacts cardiovascular disease, metabolic syndrome, and atherosclerosis. |
The molecule is a apoptosis, a energy source, and a proton trap for oxidative phosphorylation, and it impacts non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure, emulsifier, energy storage, membrane stabilizer that impacts aging. The molecule is a cholesterol translocation, a stabilizing cytochrome oxidase, and a food additive, and it impacts tangier disease. The molecule is a surfactant and a nutritional supplement, which impacts both diabetic heart disease and barth syndrome, and is characterized as smooth. |
The molecule is a membrane stabilizer and a energy source, it impacts barth syndrome, and is smooth. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, cholesterol translocation that impacts tangier disease and non-alcoholic fatty liver disease. The molecule is a emulsifier and a food additive, impacting both diabetic heart disease and aging. The molecule is a stabilizing mitochondrial structure, apoptosis, energy storage, nutritional supplement, surfactant. |
The molecule is a nutrient, fat storage, energy storage, inflammatory that impacts cardiovascular disease and obesity. This molecule is a member of the thyroxine treatment class, known to influence cancer and affect atherosclerosis. The molecule is a energy source and a membrane stabilizer, impacting both metabolic syndrome and pancreatitis. |
The molecule is a anti biotic. |
The molecule is a lpxc inhibitor. |
The molecule is a asthma treatment member of the inflammatory disease treatment class. |
The molecule is a nutrient that impacts obesity, cardiovascular disease, pancreatitis, metabolic syndrome, and atherosclerosis. The molecule is a thyroxine treatment and fat storage with an effect on cancer. The molecule is a energy storage, membrane stabilizer, energy source, inflammatory. |
The molecule is a nutrient and energy storage, belonging to the thyroxine treatment class of molecules, and impacts metabolic syndrome, obesity, and pancreatitis. The molecule is a energy source and fat storage, and it impacts cancer. The molecule is a membrane stabilizer and a inflammatory, impacting both atherosclerosis and cardiovascular disease. |
The molecule is a energy source, a membrane stabilizer, and a proton trap for oxidative phosphorylation, and it impacts tangier disease. The molecule is a nutritional supplement, emulsifier, apoptosis that impacts diabetic heart disease and non-alcoholic fatty liver disease. The molecule is a surfactant, a food additive, and a energy storage, and it impacts aging. The molecule is a stabilizing mitochondrial structure, a stabilizing cytochrome oxidase, and a cholesterol translocation, it impacts barth syndrome and is smooth. |
The molecule is thyroxine treatment and it impacts both cardiovascular disease and pancreatitis. The molecule is a fat storage and a nutrient, impacting both atherosclerosis and metabolic syndrome. |
The molecule is a apoptosis, a nutritional supplement, and a emulsifier, and it impacts diabetic heart disease. The molecule is a energy storage, a membrane stabilizer, and a proton trap for oxidative phosphorylation, it impacts non-alcoholic fatty liver disease and is smooth. The molecule is a food additive, energy source, stabilizing mitochondrial structure, surfactant. The molecule is a stabilizing cytochrome oxidase and a cholesterol translocation that impacts aging, tangier disease, and barth syndrome. |
It belongs to both the organic electroluminescent device and electroluminescent classes of molecules. |
The molecule is a food additive and a cholesterol translocation, it impacts aging, and is smooth. The molecule is a emulsifier, nutritional supplement, apoptosis that impacts tangier disease and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase and a membrane stabilizer, impacting both non-alcoholic fatty liver disease and barth syndrome. The molecule is a energy storage, proton trap for oxidative phosphorylation, surfactant, stabilizing mitochondrial structure, energy source. |
The molecule is a irritant, a food and nutrition, fruity, sweet, and banana. The molecule is a air pollutant, bitter, fragrance, laboratory chemical, solvent. |
The molecule is a nutrient. |
It impacts both cancer treatment and hepatitis b treatment. |
It impacts metabolic syndrome, cardiovascular disease, and atherosclerosis. The molecule is a nutrient and a fat storage, impacting both pancreatitis and thyroxine treatment. |
The molecule is both a kinase inhibitor and a hsp90 inhibitor. |
The molecule is a anti cancer, a estrogen receptor modulator, and anti cancer agent. |
The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure, apoptosis that impacts aging. The molecule is a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, tangier disease, diabetic heart disease, and barth syndrome. |
The molecule is anti tumor and anti mitotic. |
It impacts cardiovascular disease, atherosclerosis, and pancreatitis. The molecule is a nutrient and fat storage, belonging to the thyroxine treatment class of molecules, and impacts metabolic syndrome. |
The molecule is a nutrient, membrane stabilizer, energy source, inflammatory that has an effect on cancer and impacts thyroxine treatment. The molecule is a fat storage and energy storage, and it impacts obesity. It impacts pancreatitis, atherosclerosis, metabolic syndrome, and cardiovascular disease. |
The molecule is a organic electroluminescent element and belongs to the electronic device class of molecules, with the characteristic of being electroluminescent. |
The molecule is a tyk2 inhibitor. |
The molecule is a nutrient that is onion and horseradish. The molecule is garlic, pungent, sulfury, and vegetable. |
The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts aging and non-alcoholic fatty liver disease. The molecule is a cholesterol translocation and a apoptosis that impacts barth syndrome, tangier disease, and diabetic heart disease. |
The molecule is a pi3 kinase inhibitor. |
The molecule is a membrane stabilizer and a energy storage that impacts obesity, atherosclerosis, thyroxine treatment, and pancreatitis. The molecule is a inflammatory and energy source, and it impacts metabolic syndrome. The molecule is a fat storage and a nutrient, with effects on cancer and impacts on cardiovascular disease. |
The molecule is a stabilizing cytochrome oxidase, apoptosis, proton trap for oxidative phosphorylation that impacts barth syndrome and aging. The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts tangier disease, non-alcoholic fatty liver disease, and diabetic heart disease. |
It impacts alzheimer's treatment. |
The molecule is a liquid crystal display device. |
The molecule is a energy source that impacts diabetes mellitus type 2, inflammatory bowel disease, and cardiovascular disease. It impacts celiac disease, renal cell carcinoma, heart failure, and breast cancer. |
It belongs to the light-emitting class of molecules. |
The molecule is a acat inhibitor, a atherosclerosis treatment, and anti atherosclerotic. |